Quicknotes

From the Winter 2016 edition of Vanderbilt Medicine Magazine

Compound developed at VUMC may delay Huntington’s disease  A compound developed by researchers at Vanderbilt University can improve early symptoms and delay progression of Huntington’s disease in a mouse model of the neurodegenerative disorder. The findings, reported in the Proceedings of … Continued

Quicknotes

From the Summer 2015 edition of Vanderbilt Medicine Magazine

Antibiotics with anticancer potential The type II topoisomerases—enzymes that manage tangles and supercoils in DNA—exist in all organisms and are important drug targets. Widely prescribed anticancer agents including etoposide and doxorubicin target human type II topoisomerases, and quinolone antibiotics such as ciprofloxacin target … Continued

Q+A: Michelle Izmaylov

From the Summer 2015 edition of Vanderbilt Medicine Magazine

Michelle Izmaylov is a third-year medical student from Atlanta, and a successful writer of fantasy-fiction books for young adults. Izmaylov, 24, has already published three novels and one novella and received several literary awards including the 2010 Blumenthal Award for … Continued